Clinical investigation in highly disease-affected rheumatoid arthritis patients in Japan with adalimumab applying standard and general evaluation: the CHANGE study

por Miyasaka, Nobuyuki
Publicado 2008

Revised list of acronyms

por Miyasaka, Nobuyuki
Publicado 2005

Guidelines for the proper use of etanercept in Japan

por Miyasaka, Nobuyuki, Takeuchi, Tsutomu, Eguchi, Katsumi
Publicado 2006

Effect of a small molecule inhibitor of nuclear factor-κB nuclear translocation in a murine model of arthritis and cultured human synovial cells

por Wakamatsu, Kyoko, Nanki, Toshihiro, Miyasaka, Nobuyuki, Umezawa, Kazuo, Kubota, Tetsuo
Publicado 2005

Identification of a human peripheral blood monocyte subset that differentiates into osteoclasts

por Komano, Yukiko, Nanki, Toshihiro, Hayashida, Kenji, Taniguchi, Ken, Miyasaka, Nobuyuki
Publicado 2006

Impact of trough serum level on radiographic and clinical response to infliximab plus methotrexate in patients with rheumatoid arthritis: results from the RISING study

por Takeuchi, Tsutomu, Miyasaka, Nobuyuki, Inoue, Kazuhiko, Abe, Tohru, Koike, Takao
Publicado 2009

miR-31 controls osteoclast formation and bone resorption by targeting RhoA

por Mizoguchi, Fumitaka, Murakami, Yousuke, Saito, Tetsuya, Miyasaka, Nobuyuki, Kohsaka, Hitoshi
Publicado 2013

Effects of intravenous immunoglobulin therapy in Japanese patients with polymyositis and dermatomyositis resistant to corticosteroids: a randomized double-blind placebo-controlled...

por Miyasaka, Nobuyuki, Hara, Masako, Koike, Takao, Saito, Eizo, Yamada, Masahito, Tanaka, Yoshiya
Publicado 2011

Study of active controlled tocilizumab monotherapy for rheumatoid arthritis patients with an inadequate response to methotrexate (SATORI): significant reduction in disease activity...

por Nishimoto, Norihiro, Miyasaka, Nobuyuki, Yamamoto, Kazuhiko, Kawai, Shinichi, Takeuchi, Tsutomu, Azuma, Junichi, Kishimoto, Tadamitsu
Publicado 2008

Baseline tumour necrosis factor alpha levels predict the necessity for dose escalation of infliximab therapy in patients with rheumatoid arthritis

por Takeuchi, Tsutomu, Miyasaka, Nobuyuki, Tatsuki, Yoshihiko, Yano, Toshiro, Yoshinari, Toru, Abe, Tohru, Koike, Takao
Publicado 2011

Adalimumab discontinuation in patients with early rheumatoid arthritis who were initially treated with methotrexate alone or in combination with adalimumab: 1 year outcomes of the...

por Tanaka, Yoshiya, Yamanaka, Hisashi, Ishiguro, Naoki, Miyasaka, Nobuyuki, Kawana, Katsuyoshi, Hiramatsu, Katsutoshi, Takeuchi, Tsutomu
Publicado 2016

High titers of both rheumatoid factor and anti-CCP antibodies at baseline in patients with rheumatoid arthritis are associated with increased circulating baseline TNF level, low dr...

por Takeuchi, Tsutomu, Miyasaka, Nobuyuki, Inui, Takashi, Yano, Toshiro, Yoshinari, Toru, Abe, Tohru, Koike, Takao
Publicado 2017

Interleukin-23 as a therapeutic target for inflammatory myopathy

por Umezawa, Natsuka, Kawahata, Kimito, Mizoguchi, Fumitaka, Kimura, Naoki, Yoshihashi-Nakazato, Yoko, Miyasaka, Nobuyuki, Kohsaka, Hitoshi
Publicado 2018

NF-κB inhibitor dehydroxymethylepoxyquinomicin suppresses osteoclastogenesis and expression of NFATc1 in mouse arthritis without affecting expression of RANKL, osteoprotegerin or m...

por Kubota, Tetsuo, Hoshino, Machiko, Aoki, Kazuhiro, Ohya, Keiichi, Komano, Yukiko, Nanki, Toshihiro, Miyasaka, Nobuyuki, Umezawa, Kazuo
Publicado 2007

A multicenter, open-label, efficacy, pharmacokinetic, and safety study of adalimumab in Japanese patients with ankylosing spondylitis

por Kobayashi, Shigeto, Harigai, Masayoshi, Mozaffarian, Neelufar, Pangan, Aileen L., Sharma, Shringi, Brown, L. Steven, Miyasaka, Nobuyuki
Publicado 2011

Low disease activity for up to 3 years after adalimumab discontinuation in patients with early rheumatoid arthritis: 2-year results of the HOPEFUL-3 Study

por Tanaka, Yoshiya, Yamanaka, Hisashi, Ishiguro, Naoki, Miyasaka, Nobuyuki, Kawana, Katsuyoshi, Kimura, Junko, Agata, Naoki, Takeuchi, Tsutomu
Publicado 2017

Chemokine receptor expression and functional effects of chemokines on B cells: implication in the pathogenesis of rheumatoid arthritis

por Nanki, Toshihiro, Takada, Kazuki, Komano, Yukiko, Morio, Tomohiro, Kanegane, Hirokazu, Nakajima, Atsuo, Lipsky, Peter E, Miyasaka, Nobuyuki
Publicado 2009

Phase III, multicenter, open-label, long-term study of the safety of abatacept in Japanese patients with rheumatoid arthritis and an inadequate response to conventional or biologic...

por Takeuchi, Tsutomu, Matsubara, Tsukasa, Urata, Yukitomo, Suematsu, Eiichi, Ohta, Shuji, Honjo, Shigeru, Abe, Tohru, Yamamoto, Ami, Miyasaka, Nobuyuki
Publicado 2014

Cannabinoid receptor 2 as a potential therapeutic target in rheumatoid arthritis

por Fukuda, Shin, Kohsaka, Hitoshi, Takayasu, Aiko, Yokoyama, Waka, Miyabe, Chie, Miyabe, Yoshishige, Harigai, Masayoshi, Miyasaka, Nobuyuki, Nanki, Toshihiro
Publicado 2014

Biologic-free remission of established rheumatoid arthritis after discontinuation of abatacept: a prospective, multicentre, observational study in Japan

por Takeuchi, Tsutomu, Matsubara, Tsukasa, Ohta, Shuji, Mukai, Masaya, Amano, Koichi, Tohma, Shigeto, Tanaka, Yoshiya, Yamanaka, Hisashi, Miyasaka, Nobuyuki
Publicado 2015